Assistant AttendingMemorial Sloan Kettering Cancer Center, United States
Improved Local Control at the Cost of Reduced Lymphocyte Count: A Propensity Score-Matched Analysis of Yttrium-90 Radioembolization versus Hepatic Arterial Embolization for Hepatic Metastatic Melanoma
Monday, March 31, 20253:27 PM – 3:36 PM CT
SF3B1 and BAP1 Mutations Predict Survival Outcomes in Metastatic Uveal Melanoma Treated with Hepatic Artery Embolization
Tuesday, April 1, 20253:45 PM – 3:54 PM CT
.jpg)